Transitions launches Signature VII lenses with Chromea7 technology

Article

This new lens will replace Transitions Signature VI lenses when available in January 2014.

Las Vegas-Transitions Optical, Inc. has launched Transitions Signature VII lenses with Chromea7 technology. Available in early January 2014, Transitions Signature VII lenses will replace Transitions VI lenses in the Transitions family.

Transitions Optical developed Transitions Signature VII lenses to be more responsive in more situations, testing them in more than 200 conditions representing real-life lighting situations including various temperatures, weather conditions, and geographies. Transitions Signature VII lenses use the patented Chromea7 technology, an exclusive dye formulation that allows the lenses to be more reactive to indirect sunlight and reflected sunlight, and become even darker on hot days.

Transitions Signature VII lenses will be offered in gray and brown.

Visit TransitionsSignature.com order a free launch kit, after completing an online quiz on the site. The launch kit will include a product information sheet, frequently asked questions and answers, and technical product notes.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
© 2025 MJH Life Sciences

All rights reserved.